Global Medicated Adhesive Patch Market Growth 2024-2030

Global Medicated Adhesive Patch Market Growth 2024-2030

A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. An advantage of a transdermal drug delivery route over other types of medication delivery (such as oral, topical, intravenous, or intramuscular) is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

The global Medicated Adhesive Patch market size is projected to grow from US$ 6888.2 million in 2023 to US$ 8718.3 million in 2030; it is expected to grow at a CAGR of 3.4% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Medicated Adhesive Patch Industry Forecast” looks at past sales and reviews total world Medicated Adhesive Patch sales in 2023, providing a comprehensive analysis by region and market sector of projected Medicated Adhesive Patch sales for 2024 through 2030. With Medicated Adhesive Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medicated Adhesive Patch industry.

This Insight Report provides a comprehensive analysis of the global Medicated Adhesive Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medicated Adhesive Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medicated Adhesive Patch market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medicated Adhesive Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medicated Adhesive Patch.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report presents a comprehensive overview, market shares, and growth opportunities of Medicated Adhesive Patch market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others

Segmentation by application
Used to Stop Smoking Cigarettes
Used to Treat High Blood Pressure
Used to Relieve Severe Pain
Used to Treat an Overactive Bladder
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medicated Adhesive Patch market?

What factors are driving Medicated Adhesive Patch market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medicated Adhesive Patch market opportunities vary by end market size?

How does Medicated Adhesive Patch break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.